Kappa CAR T cells co-expressing kappa and CD28 CARs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kappa CAR T cells co-expressing kappa and CD28 CARs, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. [Phase 1]